MetaVia Inc. is trading at $2.13 (up 8.7%) in pre-market action as investors anticipate a company update on its key drug pipeline later today.
- The company is scheduled to present new information on its novel obesity and metabolic therapies at the Emerging Growth Conference at 3:25 pm ET on June 11.
- The move also follows recent volatility after stockholders approved a reverse stock split and an expansion of the company's equity incentive plan on June 8.